CD8A and neoplasm: However, the levels of CD4+CD28− and CD8+CD28− cells were significantly lower among TIL in PEF2 and PEF2+Ca-treated mice (average 17–23%) compared to tumor-bearing controls (about 30%) (Figure 6C).